Health and Healthcare
5865 Articles
The World Bank projects what the potential costs could be if the Ebola epidemic were to significantly infect people in…
AutoGenomics has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
INC Research Holdings Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.
Tekmira Pharmaceuticals downgrade also drags down Sarepta Therapeutics and BioCryst Pharmaceuticals.
Alcobra recently posted news of an FDA trial and its shares traded down about 50% Monday morning.
Chimerix has announced that its lead drug candidate has been provided for potential use in patients with Ebola virus disease.
Oppenheimer's official rating on Zogenix remains Outperform, but what stands out is that the $2.50 price target implies that shares…
The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.
Biotech company FibroGen filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering.
With the CDC not releasing enough data on the patient, there could be an opportunity for traders on both sides…
News has hit of the first confirmed Ebola case in the United States. Companies involved in potential drugs for Ebola…
ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its Phase 3 clinical trial of Firdapse for the…
Ambit Biosciences has announced that it is entering into a merger with Daiichi Sankyo in a deal worth up to…
What do you do when an analyst report comes out that maintains a price target position that implies shares can…
Alimera Sciences traded up big on Monday on news that the company received FDA approval for its diabetic macular edema…
Our top personal finance-related articles today. Your wallet will thank you later.